Purchase Order 15BCTS24P00000011

Award Date 11/15/23
Potential Completion Date 3/13/24
Potential Value $1.8K
Federal Agency
Central Office
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Clarksburg, WV, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded to Acadia Healthcare Company, Inc. by the Central Office of the U.S. Department of Health and Human Services (HHS) to provide medication-assisted treatment (MAT) at an opioid treatment program (OTP) in Baltimore, Maryland. The contract has a ceiling value of $1,406.00 and a completion date of April 11, 2024. The award was made on March 6, 2024, and there is no set-aside designation. Acadia Healthcare is a for-profit healthcare services provider...
The Department of Justice's Bureau of Prisons awarded a $7,372 firm-fixed-price purchase order to Acadia Healthcare Company, Inc. to provide medication-assisted treatment (MAT) at an opioid treatment program (OTP) in Baltimore, MD. The contract has a completion date of September 30, 2024. Acadia Healthcare is a for-profit healthcare services provider that has been awarded multiple federal contracts to deliver MAT and opioid substitution treatment services at Bureau of Prisons and Department of...
This federal contract award, valued at $6,055.56, was issued by the Department of Justice's Bureau of Prisons to Acadia Healthcare Company, Inc. for the provision of Medication-Assisted Treatment (MAT) services at an Opioid Treatment Program (OTP) facility in Wichita, Kansas. The contract is a firm-fixed-price purchase order with a period of performance ending on September 30, 2024. Acadia Healthcare, a for-profit behavioral health and addiction treatment services provider, has received multiple...
This is a firm-fixed-price purchase order awarded by the Central Office, a civilian agency, to Acadia Healthcare Company, Inc. for Medication-Assisted Treatment (MAT) services at an Opioid Treatment Program (OTP) in Boston, MA. The contract has a ceiling value of $19,485.00 and a completion date of September 30, 2025. The contract was awarded on March 13, 2025 and does not utilize a set-aside designation. Acadia Healthcare Company, Inc. is a for-profit healthcare services provider specializing...
This federal contract award is for the delivery of pharmaceutical products, specifically medication-assisted treatment (MAT) and medication for opioid use disorder (MOUD), to the United States Penitentiary McCreary, a civilian federal agency. The prime contractor is Mckesson Corporation, a healthcare services and information technology company that provides pharmaceuticals, medical supplies, and healthcare IT solutions to government agencies. The contract has a ceiling value of $308,128.64 and...
This is a firm fixed-price delivery order awarded to Wellpath LLC, doing business as Recovery Solutions, by the Federal Bureau of Prisons to provide Medication Assisted Treatment (MAT) services nationwide. The $9,661,250.00 contract has an ultimate completion date of September 30, 2025. Wellpath, a for-profit limited liability company, is an experienced provider of comprehensive healthcare services to correctional facilities, including medical, dental, behavioral health, pharmacy, and telehealth...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Baart Behavioral Health Services, Inc. (BBHS), a for-profit provider of opioid addiction treatment and rehabilitation services. The contract, valued at $261,035.40, is for the payment of delinquent invoices for methadone treatment services provided to the VA's Veterans Integrated Service Network 21. The contract has no set-aside designation and the period of performance ends on September 30, 2015....
The federal contract award is for the provision of medications under the Medication-Assisted Treatment (MAT) Program. The prime contractor is Mckesson Corporation, a healthcare services and information technology company that provides pharmaceuticals and medical supplies to government agencies. The contract has a ceiling value of $57,899.88 and is a firm fixed price delivery order awarded by the Federal Correctional Institution Bastrop, which is part of the U.S. Department of Justice. The...
This federal contract award is for the provision of various medication-assisted treatment (MAT) medications for the inmate population at the Federal Correctional Complex (FCC) Oakdale in FY25. The contract was awarded to Mckesson Corporation, a prominent healthcare services and IT company, and has a ceiling value of $71,203.46. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of March 31, 2025. No set-aside designation was used for...
This is a firm fixed price delivery order contract awarded by the Federal Correctional Complex Forrest City, a civilian agency under the Department of Justice, to Mckesson Corporation for the provision of Medication-Assisted Treatment (MAT) medication. The contract has a ceiling value of $130,000.00 and an ultimate completion date of February 20, 2024. Mckesson Corporation is the prime contractor and no set-aside designation was used. The contract is part of Mckesson's ongoing support of federal...

This federal contract award to Acadia Healthcare Company, Inc., doing business as Acadia Healthcare, is for the provision of Medication-Assisted Treatment (MAT) services at an Opioid Treatment Program (OTP) in Clarksburg, West Virginia. The contract is a firm-fixed-price purchase order with a ceiling value of $1,800 and an ultimate completion date of March 13, 2024. The award was made by the Central Office, a civilian agency within the federal government. Acadia Healthcare is a for-profit healthcare services provider that specializes in behavioral health and addiction treatment services, including MAT for opioid addiction. The company has previously received multiple federal contract and grant awards to deliver substance abuse treatment services, particularly opioid substitution therapy and MAT, at various facilities across the United States. This contract does not utilize a set-aside designation.

Generated 7/19/24, 9:28 AM